SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI United States of America flag

SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions

Example Organization: SampleLabelerOrganization

Page standards status: Informative

Generated Narrative: Organization SampleLabelerOrganization

identifier: urn:oid:1.3.6.1.4.1.519.1/999999999, urn:oid:2.16.840.1.113883.6.69/55555

type: An organization that submits product labels.

name: National Pharma of India Inc.

Contacts

-NameTelecomAddress
*Mr. John Doe_1+9-140-1111-2222, jdoe_1@npoiinc.netPlot 101 First Street RangareddyDistrict Telangana 500001 IND

Generated Narrative: OrganizationAffiliation #SampleLabelerUSAgentAffiliation

organization: Organization National Pharma of India Inc.

participatingOrganization: Organization National Pharma of India Inc. US Agent

code: UNITED STATES AGENT

Generated Narrative: Organization #usagent

identifier: urn:oid:1.3.6.1.4.1.519.1/888888888

type: An organization that acts on the behalf of a Labeler or Establishment in the US.

name: National Pharma of India Inc. US Agent

Contacts

-Telecom
*+1-908-999-1212, jdoe_2@npoiinc.net

Generated Narrative: HealthcareService #SampleLabelerBusinessOperation

providedBy: Organization National Pharma of India Inc.

type: manufacture

serviceProvisionCode: Manufactures human prescription drug products